Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 32 (RPL21P32)

Target
RPL21P32
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 32 (RPL21P32) is a processed pseudogene mapped to the human genome that shares sequence homology with the protein-coding RPL21 gene, which encodes a structural component of the ribosomal 60S subunit. Pseudogenes such as RPL21P32 are generally non-functional remnants of genes in the human genome and do not encode an active protein product. While some pseudogenes have been implicated in regulatory roles, there is currently no evidence that RPL21P32 has biological function, is relevant in disease, or serves as a therapeutic target. This distinguishes it from the parental RPL21 gene, which is functionally important in ribosome assembly and associated with diseases like hereditary hypotrichosis when mutated. RPL21P32 is therefore not a canonical drug target, receptor, enzyme, or disease biomarker.

Other names
RPL21_13_305RPL21P32
02

Mechanism of action

None documented

03

Biological functions

None established; pseudogenes may have regulatory roles, but no specific function is documented for RPL21P32
04

Disease associations

None known or established; no disease association reported

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 32 (RPL21P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 32 (RPL21P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call